The BRI1 antibody (AS12 1859) is a polyclonal antibody produced in rabbits using a synthetic peptide derived from the Arabidopsis thaliana BRI1 protein (Uniprot: O22476, TAIR: AT4G39400) . It is affinity-purified for high specificity and primarily used to detect BRI1 in Western blot (WB) and immunoprecipitation (IP) assays. BRI1 is a plasma membrane-localized leucine-rich repeat receptor-like kinase (LRR-RLK) critical for BR perception and signal transduction .
Western Blot Analysis: The antibody detects BRI1 in microsomal protein extracts, confirming its expression and post-translational modifications. For example, it identified BRI1 ubiquitination in studies exploring BR-induced receptor degradation .
Subcellular Localization: Immunoblots using this antibody demonstrated BRI1’s plasma membrane localization and its reduced endocytosis in pub12pub13 mutants .
Phosphorylation: The antibody helped characterize BRI1’s autophosphorylation on serine, threonine, and tyrosine residues (e.g., Tyr-831, Thr-880, Thr-1049) .
Ubiquitination: It detected ubiquitinated BRI1 in assays examining PUB12/PUB13 E3 ligase-mediated receptor degradation .
Co-Immunoprecipitation (Co-IP): The antibody co-precipitated BRI1 with its coreceptor BAK1 and E3 ligases like PUB13, revealing BR-induced complex formation .
The antibody confirmed BRI1’s role as a dual-specificity kinase through in vitro assays, showing phosphorylation on tyrosine residues (e.g., Tyr-956, Tyr-1072) in addition to serine/threonine residues .
Mutational studies (e.g., bri1-101 kinase domain mutant) revealed reduced kinase activity, impacting BR signaling .
Ubiquitination and Stability: BRI1 antibody-based assays showed that PUB12/PUB13 E3 ligases promote BRI1 ubiquitination, while deubiquitinating enzymes UBP12/UBP13 stabilize it .
Ligand-Induced Changes: BL (brassinolide) treatment increased BRI1-PUB13 association and phosphorylation, as demonstrated via IP-WB workflows .